Molecular mechanisms of drug resistance.
Mader
R M
RM
Department of Medicine, Medical University of Vienna, Austria. robert.mader@meduniwien.ac.at
Schmidt
W M
WM
Steger
G G
GG
Krupitza
G
G
D000964:Antimetabolites, Antineoplastic / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D002448:Cell Adhesion / Q000187:drug effects; D045744:Cell Line, Tumor; D003110:Colonic Neoplasms / Q000235:genetics / Q000473:pathology; D004260:DNA Repair; D004261:DNA Replication; D004305:Dose-Response Relationship, Drug; D019008:Drug Resistance, Neoplasm; D044127:Epigenesis, Genetic; D005260:Female; D005472:Fluorouracil / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D015870:Gene Expression; D016158:Genes, p53 / Q000235:genetics; D006801:Humans; D008745:Methylation; D008938:Mitosis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics; D015398:Signal Transduction / Q000187:drug effects; D051981:Uracil-DNA Glycosidase
D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil; D018719:Erb-b2 Receptor Tyrosine Kinases; D051981:Uracil-DNA Glycosidase